Education is an important part of the MSG mission statement: Education - Championing excellence and innovation in the development and delivery of evidence-based medical knowledge in invasive fungal disease management for patients globally. The MSGERC sets an annual educational agenda based on current evidence in mycology and collaborates with the Education Committee and educational consultants to organize a variety of shared learning activities that meet the learning needs of infectious disease specialists, adult and pediatric internists, pharmacists, health care practitioners, and researchers. MSGERC educational offerings may range from high-level international forums, “air lifted” educational conferences and symposia and enduring activities providing web-accessible continuing medical education. These programs are generally for practitioners aiming to provide the best prevention, diagnosis and treatment of invasive fungal infections in normal and immunocompromised patient populations.
NEW CME ACTIVITY- Funguscme.org
Jointly provided by Postgraduate Institute for Medicine; Terranova Medica, LLC; and the Mycoses Study Group Education & Research Consortium.
This activity is supported by an independent educational grant from F2G.
ID in Motion
The YouTube channel “ID in Motion” is now online.
A first video has been posted and we will post more every ten days, five more videos are already shot, four cut, and we continue to tape more videos diligently. Please take a look at tinyurl.com/y3978gga.
You can also follow @CornelyOliver via Twitter, where new videos will be announced every 10 days!
Mycosis in the COVID Era
Monthly Virtual Meetings - June - September 2020
Meetings are presented in Spanish
These meetings are organized by the IMEMA committee in conjunction with the Argentine Association for Microbiology. More than 200 attended the session in June and more than 280 attended the session in July. MSGERC members, Dr. Tom Chiller (June) and Dr. Luis Ostrosky (July) were invited speakers. Recorded session are available here.
August HIV - COVID and Mycoses
September Endemic Mycoses and COVID
We invite you to participate in the latest toolkit update: The New Antifungal Toolkit 2019: Review of Itraconazole Formulations and Application in Endemic Mycoses. In the first section, Dr Russell Lewis and Dr Dimitrios P. Kontoyiannia provide an overview of conventional itraconazole capsules as well as the IV formulation. They then review the profile of SUBA-itraconazole, an itraconazole formulation with enhanced bioavailability that recently became commercially available in the United States. In the second section, Dr George Thompson provides an update on endemic mycoses, including a discussion of the place for SUBA-itraconazole in therapy. We hope you find this toolkit helpful in your care of patients with invasive fungal infections who are candidates for itraconazole therapy.
At the conclusion of this activity, the participants will be better able to:
Dimitrios P. Kontoyiannis, MD, ScD, FACP, FIDSA, PhD Hon, FECMM, FAAM
Russell E. Lewis, PharmD, FCCP, BCPS
George R. Thompson III, MD, FACP
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Doctor Fungus Website
The DrFungus website was launched in the early 2000s and featured at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), December 2001. The original website was spearheaded by Dr John Rex and a team of collaborators from 3 continents and a dedicated web designer. Over the last decade, the site became dormant. In 2016 MSGERC relaunched the website under a new design and branding. With the initial sponsorship by Astellas, the site is publicly available at www.drfungus.org. This website features key updated encyclopedic features of the original site and includes Case of the Month. To submit a case of the month, contact Peter G. Pappas, MD
The MSGERC hosts a conference every two years whereby the fungal "state of the science" is presented by key opinion leaders in pre-clinical, veterinary, clinical areas. The MSGERC Biennial Meeting provides an opportunity to generate new research concepts to address current and emerging unmet needs. During this meeting academic investigators, junior investigators/fellows, private infectious disease practitioners, industry and government members join together for these common aims.
The Mycoses Study Group Education and Research Consortium (MSGERC) builds on its thirty-eight year legacy of scientific and academic expertise in mycology to collectively understand the needs of healthcare professionals in the field of mycology, institutions and companies worldwide. These include, but are not limited to the following:
The MSGERC works with infectious disease key opinion leaders who have a broad range of expertise in a wide variety of patient populations, including oncology, rheumatology, pediatrics, HIV, and tropical medicine. During its Biennial Meeting, the MSGERC invites key opinion leaders to present current pre-clinical, genomic, epidemiologic and clinical lectures addressing Endemic Mycoses, Cryptococcosis, Candidiasis, and Aspergillosis. Each set of lectures is followed by facilitated discussions. Video-taped lectures are featured on the MSGERC Youtube channel, Doctor Fungus website, and CDC Websites to disseminate information and learning opportunities.
The MSGERC works in tandem with key CME providers Terranova Medica, LLC and University of Nebraska Center of Continuing Education, School of Medicine.Many CMEs are currently available at the MSGERC Continuing Education Portal www.FungusCME.org.
For your convenience, we have listed upcoming meetings for 2020-2021. You may see some of our members on the agenda.
|INFOCUS||October 17 and October 24, 2020||https://www.infocuslatam.com.br/home.asp||Online|
|ID Week||October 21 - 25, 2020||https://idweek.org/||Online|
|Federation of Infection Societies||November 9 - 11, 2020||https://www.his.org.uk/training-events/fis-his-2020/||Online|
|International Immunocompromised Host Society||January 31 - February 2, 2021||https://www.ichs.org/||Melbourne, Australia|
|MSGERC||May 18 - 21, 2021||https://msgerc.org||Albuquerque, New Mexico|
|ASM Microbe||June 3 – 7, 2021||https://asm.org/Events/ASM-Microbe/Home||
|International Conference on Cryptococcus & Cryptococcosis||June 7 - 11, 2021||https://www.iccc2020.org/||
Speke Resort Munyoyo
|Trends in Medical Mycology||October 8 - 11, 2021||https://www.timm2021.org/||Aberdeen, Scotland, United Kingdom|
In addition to our long-standing commitment to generating educational outreach, MSG-member scholarly activities continue to contribute to awareness and education of mycology topics and treatment guidelines globally, including:
George Thompson, MD, Chair (US)
John Baddley, MD, Co-Chair (US)
Ilan Schwartz- Co-Chair, Social Media (US)
Joe Vazquez- Co-Chair, Case of the Month (US)
Peter Pappas, MD- Co-Chair, Biennial Meeting, Patient Advocacy
Barbara Alexander, MD (US)
David Andes, MD (US)
David Boulware (US)
Oliver Cornely, MD (DRG)
Dimitrios Kontoyiannis, MD (US)
Bart-Jan Kullberg, MD (NL)
Luis Ostrosky-Zeichner, MD (US)
Tom Patterson, MD (US)
John Perfect, MD (US)
Marisa Micheli, MD (US)
Monica Slavin, MD (AU)
Carolynn Thomas Jones, DNP, MSPH, RN, (MSGERC Executive Director) (US)
Alisa Peinhardt, MAIS, RN (MSGERC Clinical Operations Director) (US)
Lisa Tushla, PhD (Educational Consultant)
Tom Davis (Educational Consultant)
Last Updated 9/9/19